Therefore, we speculated about a beneficial effect to myopathy by counterbalancing the desensitised natriuretic peptide signalling in heart failure[15] and performed subsequently a pharmacological intervention: combined inhibition of the renin-angiotensin system and neprilysin (RAS/NEP) was compared to placebo in heart failure animals. This evidence concerns the gene MME and heart failure.